StartupSuperb

Arboreal Bioinnovations Secures ₹230 Crore in Series A Funding Round with Edelweiss EAAA and Omnivore at the Helm

Arboreal Bioinnovations Secures ₹230 Crore in Series A Funding Round with Edelweiss EAAA and Omnivore at the Helm



Arboreal Bioinnovations Raises Rs 230 Crore in Series A Funding


Arboreal Bioinnovations Raises Rs 230 Crore in Series A Funding

Arboreal Bioinnovations, known for its innovative technology in specialty food and nutraceutical ingredients, has successfully raised Rs 230 crore (over $24 million) in a Series A funding round. This round was co-led by EAAA, the alternatives division of Edelweiss, alongside Omnivore, with support from existing investor Rainmatter by Zerodha. The funds will be utilised to enhance manufacturing capacity, bolster research and development, and expedite the commercialisation of its advanced functional ingredients, as reported in a company press release.

About Arboreal Bioinnovations

Established in May 2018 by Swati Pandey and Manish Chauhan, Arboreal Bioinnovations focuses on creating unique ingredients and solutions for brands in the nutraceutical and food and beverage sectors. Based in Lucknow, the company offers ingredient and supply chain solutions across various categories, including next-generation proteins, sugar reduction alternatives, cocoa components, and nutraceutical actives. Their products are utilised by food, beverage, and consumer packaged goods (CPG) companies to cater to the Indian market, with Arboreal currently serving over 1,100 B2B clients across India.

Focused on Contextual Innovation

The company’s strategy is centred on a contextual innovation approach, allowing it to develop ingredient solutions specifically tailored to meet the nutritional, functional, sensory, and commercial needs of Indian consumers and brands. This method has proven successful in enabling numerous food, beverage, and nutraceutical brands to create and scale new products.

Technological Advancements in Ingredient Development

A cornerstone of Arboreal’s operations is its ingredient technology platform, which integrates ingredient engineering, process research and development, formulation science, and precision manufacturing. The company has successfully commercialised proprietary ingredients in areas such as next-generation proteins, cocoa components, natural zero-calorie sweeteners, and functional fibres. Furthermore, additional ingredient platforms are currently under development to expand their offerings.


Exit mobile version